Skip to main content

Targeted Anti-Cancer Therapies

Project description

Next-generation protein-drug conjugates for cancer therapy

Field of science

  • /medical and health sciences/clinical medicine/cancer

Call for proposal

H2020-MSCA-ITN-2019
See other projects for this call

Funding Scheme

MSCA-ITN-ETN - European Training Networks

Coordinator

UNIVERSITE DE STRASBOURG
Address
Rue Blaise Pascal 4
67081 Strasbourg
France
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 549 604,08

Participants (8)

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
France
EU contribution
€ 274 802,04
Address
Rue Michel Ange 3
75794 Paris
Activity type
Research Organisations
UNIVERSITY COLLEGE LONDON
United Kingdom
EU contribution
€ 303 172,56
Address
Gower Street
WC1E 6BT London
Activity type
Higher or Secondary Education Establishments
THE QUEEN'S UNIVERSITY OF BELFAST
United Kingdom
EU contribution
€ 606 345,12
Address
University Road Lanyon Building
BT7 1NN Belfast
Activity type
Higher or Secondary Education Establishments
WAGENINGEN UNIVERSITY
Netherlands
EU contribution
€ 265 619,88
Address
Droevendaalsesteeg 4
6708 PB Wageningen
Activity type
Higher or Secondary Education Establishments
TECHNISCHE UNIVERSITAET MUENCHEN
Germany
EU contribution
€ 252 788,40
Address
Arcisstrasse 21
80333 Muenchen
Activity type
Higher or Secondary Education Establishments
HEIDELBERG PHARMA RESEARCH GMBH
Germany
EU contribution
€ 252 788,40
Address
Gregor Mendel Strasse 22
68526 Ladenburg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ALMAC DISCOVERY LTD
United Kingdom
EU contribution
€ 303 172,56
Address
Almac House, 20 Seagoe Industrial Estate
BT63 5QD Craigavon
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
SPIROCHEM AG
Switzerland
EU contribution
€ 281 276,64
Address
Mattenstrasse 24
4058 Basel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)